Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Irving D. Kaplan, M.D.

TitleAssistant Professor of Radiation Oncology
InstitutionBeth Israel Deaconess Medical Center
DepartmentRadiation Oncology
AddressBeth Israel Deaconess Med Ctr
Radiation Oncology
330 Brookline Ave
Boston MA 02215
Phone617/632-8502
Fax617/632-0339

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Aizer AA, Paly JJ, Zietman AL, Nguyen PL, Beard CJ, Rao SK, Kaplan ID, Niemierko A, Hirsch MS, Wu CL, Olumi AF, Michaelson MD, D'Amico AV, Efstathiou JA. Models of Care and NCCN Guideline Adherence in Very-Low-Risk Prostate Cancer. J Natl Compr Canc Netw. 2013 Nov 1; 11(11):1364-72.
    View in: PubMed
  2. King CR, Freeman D, Kaplan I, Fuller D, Bolzicco G, Collins S, Meier R, Wang J, Kupelian P, Steinberg M, Katz A. Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials. Radiother Oncol. 2013 Nov; 109(2):217-21.
    View in: PubMed
  3. Hamstra DA, Conlon AS, Daignault S, Dunn RL, Sandler HM, Hembroff AL, Zietman AL, Kaplan I, Ciezki J, Kuban DA, Wei JT, Sanda MG, Michalski JM. Multi-institutional Prospective Evaluation of Bowel Quality of Life After Prostate External Beam Radiation Therapy Identifies Patient and Treatment Factors Associated With Patient-Reported Outcomes: The PROSTQA Experience. Int J Radiat Oncol Biol Phys. 2013 Jul 1; 86(3):546-53.
    View in: PubMed
  4. Bubley GJ, Bloch BN, Vazquez C, Genega E, Holupka E, Rofsky N, Kaplan I. Accuracy of endorectal magnetic resonance/transrectal ultrasound fusion for detection of prostate cancer during brachytherapy. Urology. 2013 Jun; 81(6):1284-90.
    View in: PubMed
  5. Aizer AA, Paly JJ, Zietman AL, Nguyen PL, Beard CJ, Rao SK, Kaplan ID, Niemierko A, Hirsch MS, Wu CL, Olumi AF, Michaelson MD, D'Amico AV, Efstathiou JA. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. J Clin Oncol. 2012 Sep 1; 30(25):3071-6.
    View in: PubMed
  6. McBride SM, Wong DS, Dombrowski JJ, Harkins B, Tapella P, Hanscom HN, Collins SP, Kaplan ID. Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: preliminary results of a multi-institutional phase 1 feasibility trial. Cancer. 2012 Aug 1; 118(15):3681-90.
    View in: PubMed
  7. Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsky N, Saigal CS, Litwin MS, Klein E, Kibel AS, Hamstra DA, Pisters LL, Kuban DA, Kaplan ID, Wood DP, Ciezki J, Dunn RL, Carroll PR, Sanda MG. Prediction of erectile function following treatment for prostate cancer. JAMA. 2011 Sep 21; 306(11):1205-14.
    View in: PubMed
  8. Hurwitz MD, Hansen JL, Prokopios-Davos S, Manola J, Wang Q, Bornstein BA, Hynynen K, Kaplan ID. Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer: long-term results from Dana-Farber Cancer Institute study 94-153. Cancer. 2011 Feb 1; 117(3):510-6.
    View in: PubMed
  9. Kamo N, Dandapani SV, Miksad RA, Houlihan MJ, Kaplan I, Regan M, Greenfield TK, Sanda MG. Evaluation of the SCA instrument for measuring patient satisfaction with cancer care administered via paper or via the Internet. Ann Oncol. 2011 Mar; 22(3):723-9.
    View in: PubMed
  10. Sanda MG, Kaplan ID. A 64-year-old man with low-risk prostate cancer: review of prostate cancer treatment. JAMA. 2009 May 27; 301(20):2141-51.
    View in: PubMed
  11. Sommers BD, Beard CJ, D'Amico AV, Kaplan I, Richie JP, Zeckhauser RJ. Predictors of patient preferences and treatment choices for localized prostate cancer. Cancer. 2008 Oct 15; 113(8):2058-67.
    View in: PubMed
  12. Lu XQ, Shanmugham LN, Mahadevan A, Nedea E, Stevenson MA, Kaplan I, Wong ET, La Rosa S, Wang F, Berman SM. Organ deformation and dose coverage in robotic respiratory-tracking radiotherapy. Int J Radiat Oncol Biol Phys. 2008 May 1; 71(1):281-9.
    View in: PubMed
  13. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters LL, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008 Mar 20; 358(12):1250-61.
    View in: PubMed
  14. Petit JH, Gluck C, Kiger WS, Henry DL, Karasiewicz C, Talcott J, Berg S, Holupka E, Kaplan I. Bicalutamide alone prior to brachytherapy achieves cytoreduction that is similar to luteinizing hormone-releasing hormone analogues with less patient-reported morbidity. Urol Oncol. 2008 Jul-Aug; 26(4):372-7.
    View in: PubMed
  15. Sommers BD, Beard CJ, D'Amico AV, Dahl D, Kaplan I, Richie JP, Zeckhauser RJ. Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer. Cancer. 2007 Nov 15; 110(10):2210-7.
    View in: PubMed
  16. Petit JH, Gluck C, Kiger WS, Laury Henry D, Karasiewicz C, Talcott JA, Berg S, Holupka EJ, Kaplan ID. Androgen deprivation-mediated cytoreduction before interstitial brachytherapy for prostate cancer does not abrogate the elevated risk of urinary morbidity associated with larger initial prostate volume. Brachytherapy. 2007 Oct-Dec; 6(4):267-71.
    View in: PubMed
  17. Bloch BN, Lenkinski RE, Helbich TH, Ngo L, Oismueller R, Jaromi S, Kubin K, Hawliczek R, Kaplan ID, Rofsky NM. Prostate postbrachytherapy seed distribution: comparison of high-resolution, contrast-enhanced, T1- and T2-weighted endorectal magnetic resonance imaging versus computed tomography: initial experience. Int J Radiat Oncol Biol Phys. 2007 Sep 1; 69(1):70-8.
    View in: PubMed
  18. Miksad RA, Bubley G, Church P, Sanda M, Rofsky N, Kaplan I, Cooper A. Prostate cancer in a transgender woman 41 years after initiation of feminization. JAMA. 2006 Nov 15; 296(19):2316-7.
    View in: PubMed
  19. Kaplan ID, Meskell P, Oldenburg NE, Saltzman B, Kearney GP, Holupka EJ. Real-time computed tomography dosimetry during ultrasound-guided brachytherapy for prostate cancer. Brachytherapy. 2006 Jul-Sep; 5(3):147-51.
    View in: PubMed
  20. Bues M, Holupka EJ, Meskell P, Kaplan ID. Effect of random seed placement error in permanent transperineal prostate seed implant. Radiother Oncol. 2006 Apr; 79(1):70-4.
    View in: PubMed
  21. Hurwitz MD, Kaplan ID, Hansen JL, Prokopios-Davos S, Topulos GP, Wishnow K, Manola J, Bornstein BA, Hynynen K. Hyperthermia combined with radiation in treatment of locally advanced prostate cancer is associated with a favourable toxicity profile. Int J Hyperthermia. 2005 Nov; 21(7):649-56.
    View in: PubMed
  22. Kiger WS, Lu XQ, Harling OK, Riley KJ, Binns PJ, Kaplan J, Patel H, Zamenhof RG, Shibata Y, Kaplan ID, Busse PM, Palmer MR. Preliminary treatment planning and dosimetry for a clinical trial of neutron capture therapy using a fission converter epithermal neutron beam. Appl Radiat Isot. 2004 Nov; 61(5):1075-81.
    View in: PubMed
  23. Holupka EJ, Meskell PM, Burdette EC, Kaplan ID. An automatic seed finder for brachytherapy CT postplans based on the Hough transform. Med Phys. 2004 Sep; 31(9):2672-9.
    View in: PubMed
  24. Holupka EJ, Meskell PM, Kaplan ID. Automatic detection of linear artifacts in medical images. Med Phys. 2004 Sep; 31(9):2707-10.
    View in: PubMed
  25. Tay MH, Kaufman DS, Regan MM, Leibowitz SB, George DJ, Febbo PG, Manola J, Smith MR, Kaplan ID, Kantoff PW, Oh WK. Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate. Ann Oncol. 2004 Jun; 15(6):974-8.
    View in: PubMed
  26. Seo PH, D'Amico AV, Clark JA, Kaplan I, Manola JB, Mitchell SP, Talcott JA. Assessing a prostate cancer brachytherapy technique using early patient-reported symptoms: a potential early indicator for technology assessment? Clin Prostate Cancer. 2004 Jun; 3(1):38-42.
    View in: PubMed
  27. Kaplan ID, Meskell PM, Lieberfarb M, Saltzman B, Berg S, Holupka EJ. A comparison of the precision of seeds deposited as loose seeds versus suture embedded seeds: a randomized trial. Brachytherapy. 2004; 3(1):7-9.
    View in: PubMed
  28. Talcott JA, Manola J, Clark JA, Kaplan I, Beard CJ, Mitchell SP, Chen RC, O'Leary MP, Kantoff PW, D'Amico AV. Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol. 2003 Nov 1; 21(21):3979-86.
    View in: PubMed
  29. Giaid A, Lehnert SM, Chehayeb B, Chehayeb D, Kaplan I, Shenouda G. Inducible nitric oxide synthase and nitrotyrosine in mice with radiation-induced lung damage. Am J Clin Oncol. 2003 Aug; 26(4):e67-72.
    View in: PubMed
  30. Oh WK, Manola J, Bittmann L, Brufsky A, Kaplan ID, Smith MR, Kaufman DS, Kantoff PW. Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up. Urology. 2003 Jul; 62(1):99-104.
    View in: PubMed
  31. Oh WK, Kaplan ID, Febbo P, Prisby J, Manola J, Kaufman DS, Kantoff PW. Neoadjuvant doxil chemotherapy prior to androgen ablation plus radiotherapy for high-risk localized prostate cancer: feasibility and toxicity. Am J Clin Oncol. 2003 Jun; 26(3):312-6.
    View in: PubMed
  32. Busse PM, Harling OK, Palmer MR, Kiger WS, Kaplan J, Kaplan I, Chuang CF, Goorley JT, Riley KJ, Newton TH, Santa Cruz GA, Lu XQ, Zamenhof RG. A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease. J Neurooncol. 2003 Mar-Apr; 62(1-2):111-21.
    View in: PubMed
  33. Coleman CN, Kelly L, Riese Daly N, Beard C, Kaplan I, Lamb C, Propert K, Manola J. Phase III study of ibuprofen versus placebo for radiation-induced genitourinary side effects. Int J Radiat Oncol Biol Phys. 2002 Sep 1; 54(1):191-4.
    View in: PubMed
  34. Ben-Josef E, Han S, Tobi M, Shaw LM, Bonner HS, Vargas BJ, Prokop S, Stamos B, Kelly L, Biggar S, Kaplan I. A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injury. Int J Radiat Oncol Biol Phys. 2002 Aug 1; 53(5):1160-4.
    View in: PubMed
  35. Hurwitz MD, Schnieder L, Manola J, Beard CJ, Kaplan ID, D'Amico AV. Lack of radiation dose response for patients with low-risk clinically localized prostate cancer: a retrospective analysis. Int J Radiat Oncol Biol Phys. 2002 Aug 1; 53(5):1106-10.
    View in: PubMed
  36. Hurwitz MD, Kaplan ID, Hansen JL, Prokopios-Davos S, Topulos GP, Wishnow K, Manola J, Bornstein BA, Hynynen K. Association of rectal toxicity with thermal dose parameters in treatment of locally advanced prostate cancer with radiation and hyperthermia. Int J Radiat Oncol Biol Phys. 2002 Jul 15; 53(4):913-8.
    View in: PubMed
  37. Kaplan I, Oldenburg NE, Meskell P, Blake M, Church P, Holupka EJ. Real time MRI-ultrasound image guided stereotactic prostate biopsy. Magn Reson Imaging. 2002 Apr; 20(3):295-9.
    View in: PubMed
  38. Das P, Kaplan I. The role of PC-SPES, selenium, and vitamin E in prostate cancer. Oncology (Williston Park). 2002 Mar; 16(3):285-91; discussion 291, 295-6, 299-300.
    View in: PubMed
  39. Ben-Josef E, Han S, Tobi M, Vargas BJ, Stamos B, Kelly L, Biggar S, Kaplan I. Intrarectal application of amifostine for the prevention of radiation-induced rectal injury. Semin Radiat Oncol. 2002 Jan; 12(1 Suppl 1):81-5.
    View in: PubMed
  40. D'Amico AV, Schultz D, Silver B, Henry L, Hurwitz M, Kaplan I, Beard CJ, Renshaw AA. The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2001 Mar 1; 49(3):679-84.
    View in: PubMed
  41. Hurwitz MD, Kaplan ID, Svensson GK, Hynynen K, Hansen MS. Feasibility and patient tolerance of a novel transrectal ultrasound hyperthermia system for treatment of prostate cancer. Int J Hyperthermia. 2001 Jan-Feb; 17(1):31-7.
    View in: PubMed
  42. Signoretti S, Montironi R, Manola J, Altimari A, Tam C, Bubley G, Balk S, Thomas G, Kaplan I, Hlatky L, Hahnfeldt P, Kantoff P, Loda M. Her-2-neu expression and progression toward androgen independence in human prostate cancer. J Natl Cancer Inst. 2000 Dec 6; 92(23):1918-25.
    View in: PubMed
  43. D'Amico AV, Schultz D, Loffredo M, Dugal R, Hurwitz M, Kaplan I, Beard CJ, Renshaw AA, Kantoff PW. Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer. JAMA. 2000 Sep 13; 284(10):1280-3.
    View in: PubMed
  44. Kaplan ID, Holupka EJ, Meskell P, Soon SJ, Saltzman B, Church P, Kearney GP. Intraoperative treatment planning for radioactive seed implant therapy for prostate cancer. Urology. 2000 Sep 1; 56(3):492-5.
    View in: PubMed
  45. Kaplan I. Minimizing rectal and urinary complications in prostate brachytherapy. J Endourol. 2000 May; 14(4):381-3.
    View in: PubMed
  46. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Silver B, Henry L, Hurwitz M, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Wein A, Richie JP. Clinical utility of percent-positive prostate biopsies in predicting biochemical outcome after radical prostatectomy or external-beam radiation therapy for patients with clinically localized prostate cancer. Mol Urol. 2000; 4(3):171-5;discussion 177.
    View in: PubMed
  47. McMenamin ME, Soung P, Perera S, Kaplan I, Loda M, Sellers WR. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res. 1999 Sep 1; 59(17):4291-6.
    View in: PubMed
  48. D'Amico AV, Whittington R, Malkowicz SB, Fondurulia J, Chen MH, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Wein A, Coleman CN. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol. 1999 Jan; 17(1):168-72.
    View in: PubMed
  49. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998 Sep 16; 280(11):969-74.
    View in: PubMed
  50. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Loughlin KR, Richie JP, Wein A. Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapy. J Clin Oncol. 1998 Sep; 16(9):3094-100.
    View in: PubMed
  51. Beard CJ, Lamb C, Buswell L, Schneider L, Propert KJ, Gladstone D, D'Amico A, Kaplan I. Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys. 1998 May 1; 41(2):257-62.
    View in: PubMed
  52. D'Amico AV, Whittington R, Kaplan I, Beard C, Schultz D, Malkowicz SB, Wein A, Tomaszewski JE, Coleman CN. Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter. Cancer. 1998 Jan 15; 82(2):334-41.
    View in: PubMed
  53. Talcott JA, Rieker P, Clark JA, Propert KJ, Weeks JC, Beard CJ, Wishnow KI, Kaplan I, Loughlin KR, Richie JP, Kantoff PW. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol. 1998 Jan; 16(1):275-83.
    View in: PubMed
  54. D'Amico AV, Whittington R, Kaplan I, Beard C, Schultz D, Malkowicz SB, Tomaszewski JE, Wein A, Coleman CN. Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV. Int J Radiat Oncol Biol Phys. 1997 Sep 1; 39(2):335-40.
    View in: PubMed
  55. Magi-Galluzzi C, Xu X, Hlatky L, Hahnfeldt P, Kaplan I, Hsiao P, Chang C, Loda M. Heterogeneity of androgen receptor content in advanced prostate cancer. Mod Pathol. 1997 Aug; 10(8):839-45.
    View in: PubMed
  56. Brufsky A, Fontaine-Rothe P, Berlane K, Rieker P, Jiroutek M, Kaplan I, Kaufman D, Kantoff P. Finasteride and flutamide as potency-sparing androgen-ablative therapy for advanced adenocarcinoma of the prostate. Urology. 1997 Jun; 49(6):913-20.
    View in: PubMed
  57. D'Amico AV, Whittington R, Kaplan I, Beard C, Jiroutek M, Malkowicz SB, Wein A, Coleman CN. Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml. Int J Radiat Oncol Biol Phys. 1997 Mar 15; 37(5):1053-8.
    View in: PubMed
  58. Magi-Galluzzi C, Mishra R, Fiorentino M, Montironi R, Yao H, Capodieci P, Wishnow K, Kaplan I, Stork PJ, Loda M. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. Lab Invest. 1997 Jan; 76(1):37-51.
    View in: PubMed
  59. Beard CJ, Propert KJ, Rieker PP, Clark JA, Kaplan I, Kantoff PW, Talcott JA. Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study. J Clin Oncol. 1997 Jan; 15(1):223-9.
    View in: PubMed
  60. Holupka EJ, Kaplan ID, Burdette EC, Svensson GK. Ultrasound image fusion for external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 1996 Jul 15; 35(5):975-84.
    View in: PubMed
  61. D'Amico AV, Kaplan I. Select transition zone prostate cancers may be radiocurable despite markedly elevated prostate-specific antigen levels. Radiother Oncol. 1996 Jan; 38(1):73-6.
    View in: PubMed
  62. Seiden MV, Kantoff PW, Krithivas K, Propert K, Bryant M, Haltom E, Gaynes L, Kaplan I, Bubley G, DeWolf W, et al. Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol. 1994 Dec; 12(12):2634-9.
    View in: PubMed
  63. Kaplan ID, Cox RS, Bagshaw MA. Radiotherapy for prostatic cancer: patient selection and the impact of local control. Urology. 1994 May; 43(5):634-9.
    View in: PubMed
  64. Kaplan ID, Castro JR, Phillips TL. Helium charged particle radiotherapy for meningioma: experience at UCLBL. University of California Lawrence Berkeley Laboratory. Int J Radiat Oncol Biol Phys. 1994 Jan 1; 28(1):257-61.
    View in: PubMed
  65. Cox RS, Kaplan ID, Bagshaw MA. Prostate-specific antigen kinetics after external beam irradiation for carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1994 Jan 1; 28(1):23-31.
    View in: PubMed
  66. Beard CJ, Kaplan ID, Coleman CN. The challenge for conformal therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 1993 Jul 15; 26(4):705-7.
    View in: PubMed
  67. Coleman CN, Kaplan ID. Prostate cancer. Technology versus biology. Cancer. 1993 Jul 15; 72(2):305-9.
    View in: PubMed
  68. Kaplan ID, Cox RS, Bagshaw MA. Prostate specific antigen after external beam radiotherapy for prostatic cancer: followup. J Urol. 1993 Mar; 149(3):519-22.
    View in: PubMed
  69. Bagshaw MA, Kaplan ID, Cox RC. Prostate cancer. Radiation therapy for localized disease. Cancer. 1993 Feb 1; 71(3 Suppl):939-52.
    View in: PubMed
  70. Kaplan ID, Adler JR, Hicks WL, Fee WE, Goffinet DR. Radiosurgery for palliation of base of skull recurrences from head and neck cancers. Cancer. 1992 Oct 1; 70(7):1980-4.
    View in: PubMed
  71. Kaplan ID, Bagshaw MA. Serum prostate-specific antigen after post-prostatectomy radiotherapy. Urology. 1992 May; 39(5):401-6.
    View in: PubMed
  72. Kaplan ID, Prestidge BR, Bagshaw MA, Cox RS. The importance of local control in the treatment of prostatic cancer. J Urol. 1992 Mar; 147(3 Pt 2):917-21.
    View in: PubMed
  73. Bagshaw MA, Kaplan ID, Valdagni R, Cox RS. Radiation treatment of prostate bone metastases and the biological considerations. Adv Exp Med Biol. 1992; 324:255-68.
    View in: PubMed
  74. Fuller BG, Kaplan ID, Adler J, Cox RS, Bagshaw MA. Stereotaxic radiosurgery for brain metastases: the importance of adjuvant whole brain irradiation. Int J Radiat Oncol Biol Phys. 1992; 23(2):413-8.
    View in: PubMed
  75. Kaplan ID, Bagshaw MA, Cox CA, Cox RS. External beam radiotherapy for incidental adenocarcinoma of the prostate discovered at transurethral resection. Int J Radiat Oncol Biol Phys. 1992; 24(3):415-21.
    View in: PubMed
  76. Kaplan ID, Cox RS, Bagshaw MA. A model of prostatic carcinoma tumor kinetics based on prostate specific antigen levels after radiation therapy. Cancer. 1991 Jul 15; 68(2):400-5.
    View in: PubMed
  77. Kaplan ID, Valdagni R, Cox RS, Bagshaw MA. Reduction of spinal metastases after preemptive irradiation in prostatic cancer. Int J Radiat Oncol Biol Phys. 1990 May; 18(5):1019-25.
    View in: PubMed
  78. Stevens SK, Moore SG, Kaplan ID. Early and late bone-marrow changes after irradiation: MR evaluation. AJR Am J Roentgenol. 1990 Apr; 154(4):745-50.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Kaplan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_